Table 2. Outcomes of patients by pretreatment anemia status.
N (%) | All | Hb<12g/dL | Hb≥12g/dL | ||
---|---|---|---|---|---|
N = 655 (100%) | N = 166 (25.3%) | N = 489 (74.7%) | χ2 | p | |
pCR | |||||
No | 589(89.9) | 157(94.6) | 432(88.3) | 5.317 | 0.021 |
Yes | 66(10.1) | 9(5.4) | 57(11.7) | ||
Relapse | |||||
No | 452(69.0) | 104(62.7) | 348(71.2) | 4.201 | 0.040 |
Yes | 203(31.0) | 62(37.3) | 141(28.8) | ||
Cancer-specific death | |||||
No | 607(92.7) | 143(86.1) | 464(94.9) | 13.949 | <0.001 |
Yes | 48(7.3) | 23(13.9) | 25(5.1) | ||
Death | |||||
No | 591(90.2) | 135(81.3) | 456(93.3) | 19.994 | <0.001 |
Yes | 64(9.8) | 31(18.7) | 33(6.7) |
Abbreviations: pCR: pathological complete response.